Your account is not claimed yet. You can sign up with ORCID to claim your account.

Sirac Bozkurt

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Ejection Fraction

Replacement Therapy

Patient Reported

Top Venues

International journal of hematologic oncology

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Mutlu Arat, Inci Alacacioglu, Ali Zahit Bolaman, Yahya Buyukasik, Seckin Cagirgan, Birol Guvenc, Emin Kaya, Mehmet Ali Ozcan, Ozan Salim, Filiz Vural, Mehmet Yılmaz, Meltem Kurt Yüksel, Sirac Bozkurt, Birkan Aver, Rüstü Kaya, Osman Ilhan
Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi study. Future oncology (London, England) (2023)
Guray Saydam, Rıdvan Ali, Ahmet Muzaffer Demir, Ahmet Emre Eskazan, Birol Guvenc, İbrahim Celallettin Haznedaroğlu, Mehmet Ali Ozcan, Ozan Salim, Mehmet Sonmez, Ayse Tulin Tuglular, Mehmet Turgut, Ali Unal, Birkan Aver, Sirac Bozkurt, Begum Ozdengulsun, Osman Ilhan
The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia. International journal of hematologic oncology 11 (1) (2022)
Guray Saydam, Ali Unal, İbrahim Celallettin Haznedaroğlu, Abdullah Hacıhanefioğlu, Özgür Mehta, Erdal Kurtoglu, Mesut Gocer, Mehmet Turgut, Engin Kelkitli, Memis Hilmi Atay, Nil Guler, Basak Unver Koluman, Mehmet Sonmez, Nergiz Erkut, Emin Kaya, İrfan Kuku, Mehmet Ali Erkurt, Gülsüm Özet, Funda Ceran, Fahri Şahin, Nur Akad Soyer, Meliha Nalçacı, Mehmet Yılmaz, Sirac Bozkurt, Birkan Aver, Begum Ozdengulsun, Egemen Ozbilgili, Osman Ilhan
Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemia. International journal of hematologic oncology 11 (3) (2022)